1093 On Other Exchanges
1093 is not on other exchanges.

cspc pharmaceutical group lt (1093) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CSPC PHARMACEUTICAL GROUP LT (1093)

Related News

No related news articles were found.

cspc pharmaceutical group lt (1093) Related Businessweek News

No Related Businessweek News Found

cspc pharmaceutical group lt (1093) Details

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally. It operates through Finished Drugs, Antibiotics, Vitamin C, and Caffeine and Others segments. The company offers finished drugs, such as NBP series used for acute ischemic stroke; Oulaining series primarily for the treatment of mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning series to treat hypertension and angina pectoris; Duomeisu, a chemotherapy drug for lymphoma, multiple myeloma, and ovarian and breast cancer; Jinyouli for the prevention of leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; and Nuolining, a small molecule targeted cancer drug. It also provides generic drugs, including Qingre Jiedu, Ganmao Qingre, Yin Huang, Xiangsha Yangwei, and Huoxiang Qushu soft capsules; Zhongnuo Shuluoke injection; Guoweikang health supplement products; antibiotics, vitamin C products, and caffeine and other drugs; and traditional Chinese medicines. In addition, the company has 170 products under research and development with focus on the therapeutic areas of cardio-cerebrovascular, diabetes, oncology, neurology, and anti-infection. Further, it provides pharmaceutical research and development services; storage, sourcing, and distribution services; and sewage and pharmaceutical by-products, as well as trades in pharmaceutical products and holds properties. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is headquartered in Shijiazhuang, the People’s Republic of China.

10,529 Employees
Last Reported Date: 04/19/17
Founded in 1997

cspc pharmaceutical group lt (1093) Top Compensated Officers

Executive Chairman, Chief Executive Officer a...
Total Annual Compensation: $10.9M
Vice Chairman, Chief Executive Officer, Chief...
Total Annual Compensation: $2.5M
Executive Director
Total Annual Compensation: $4.5M
Executive Director
Total Annual Compensation: $2.5M
Executive Director
Total Annual Compensation: $2.5M
Compensation as of Fiscal Year 2016.
cspc pharmaceutical group lt
CSPC Pharmaceutical Group Limited Appoints Pan Waidong as the Vice-Chairman and Rotating Chief Executive Officer

The board of directors of CSPC Pharmaceutical Group Limited announced that Mr. Pan Waidong, an executive director of the company, has been appointed as the vice-Chairman and Rotating Chief Executive Officer of the company, effective 25 May 2017. Mr. PAN is also director of Massive Giant Group Limited, Massive Top Limited and March Rise Limited.

CSPC Pharmaceutical Group Limited Announces Retirement of Wang Shunlong as Executive Director of the Company

The board of directors of CSPC Pharmaceutical Group Limited announced that Mr. Wang Shunlong, an executive director of the company, retired from office as executive director of the company at the conclusion of the annual general meeting of the company held on 25 May 2017. Mr. WANG did not offer himself for re-election at the AGM in pursuit of his career development.

CSPC Pharmaceutical Group Limited Approves Final Dividend for the Year Ended December 31, 2016

CSPC Pharmaceutical Group Limited approved final dividend of 12 HK cents per share for the year ended December 31, 2016 at the AGM held on May 25, 2017.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1093 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1093.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1093 Industry Range
Price/Earnings 31.9x
Price/Sales 5.6x
Price/Book 7.1x
Price/Cash Flow 32.0x
TEV/Sales 5.2x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CSPC PHARMACEUTICAL GROUP LT, please visit www.cspc.com.hk. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.